Pauling AI Blog

Computational CROs Won't Survive: How Companies Using AI for Drug Discovery Are Winning!

The multi billion dollar computational chemistry CRO market is collapsing faster than anyone predicted.

Nov 5 • 

Antonella Ballestas

1

October 2025

DRUG DISCOVERY WITHOUT THE HEADACHE

Too many tools, too little interoperability. Cut through license limits, fragile toolchains, and format clashes. The Pauling.AI workflow takes you from…

Oct 7 • 

Oleksandr Savytskyi

2

August 2025

IF WET LAB VALIDATION IS ESSENTIAL, WHY USE COMPUTATIONAL METHODS IN DRUG DISCOVERY?

Integrating computational and experimental methods in biology and chemistry accelerates drug discovery, reduces costs, and provides deeper molecular…

Aug 6 • 

Oleksandr Savytskyi

4

One line code change → Save thousands

Benchmarking x86 vs ARM on GCP using a cheminformatics pipeline. One build flag reduced CPU costs by over 50%, with zero changes to application logic.

Aug 4 • 

Pablo Villanueva

6

1

July 2025